Division Chief of Genetics and Metabolism Interviews FDA Expert on Rare Disease Drug Development

As part of an ongoing collaboration between the Genetics and Metabolism Division at Children's National and Medscape, Division Chief Marshall Summar, MD, interviews Dr. Gayatri Rao, director of the Office of Orphan Products Development at the US Food and Drug Administration (FDA) about the FDA’s role in developing drug therapies for rare diseases.

Watch the Medscape video and read the article here.